IN SUE'S NAME
In Sues Name has three main aims.To raise funds for research into the treatment of brain tumours.To increase public awareness about this terrible disease and the urgent need for well-funded, sustainable research.To bring together families and friends who have lost a loved one to brain cancer, or those who are still supporting them.
Objects
THE OBJECTS OF THE CIO ARE FOR THE PUBLIC BENEFIT AND SPECIFICALLY WITHIN THE AREA OF ENGLAND AND WALES:(A) TO ASSIST IN THE TREATMENT AND CARE OF PERSONS SUFFERING FROM BRAIN TUMOURS OR IN NEED OF SUPPORT AS A RESULT OF SUCH ILLNESS(B) TO PROMOTE AND PROTECT THE PHYSICAL AND MENTAL HEALTH OF SUFFERERS OF BRAIN TUMOURS IN ENGLAND AND WALES THROUGH THE PROVISION OF FINANCIAL ASSISTANCE, SUPPORT, EDUCATION AND PRACTICAL ADVICE (C) TO ADVANCE THE EDUCATION AND AWARENESS OF THE GENERAL PUBLIC IN ALL AREAS RELATING TO BRAIN TUMOURS(D) TO PROVIDE GRANTS TO FUND RESEARCH INTO THE PREVENTION AND CURE OF BRAIN TUMOURS.NOTHING IN THIS CONSTITUTION SHALL AUTHORISE AN APPLICATION OF THE PROPERTY OF THE CIO FOR THE PURPOSES WHICH ARE NOT CHARITABLE IN ACCORDANCE WITH [SECTION 7 OF THE CHARITIES AND TRUSTEE INVESTMENT (SCOTLAND) ACT 2005] AND [SECTION 2 OF THE CHARITIES ACT (NORTHERN IRELAND) 2008]
Financial health, per its FY2024 accounts
The accounts state that total funds increased from £27,420 to £82,712, driven by net incoming resources of £55,292 against total expenditure of £144,845. The charity holds no fixed assets and maintains unrestricted reserves of £82,712, with no disclosed reserves policy target or material uncertainties regarding its ability to continue as a going concern.
What the accounts disclose
Policies the charity declares
- Internal charity financial controls policy and procedures
Funders the charity credits
- Aventum Group
Trustees
- CRAIG RYDQVISTchair
- DANIELLA SAMATHY
- Jeremy Silverstone
- Lawrence Thor Stevens
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £144k | £88k |
| 31/12/2023 | £61k | £56k |
| 31/12/2022 | £73k | £63k |
| 31/12/2021 | £78k | £91k |
| 31/12/2020 | £40k | £48k |
Common questions
Is IN SUE'S NAME financially healthy?
Per its FY2024 accounts: The accounts state that total funds increased from £27,420 to £82,712, driven by net incoming resources of £55,292 against total expenditure of £144,845. The charity holds no fixed assets and maintains unrestricted reserves of £82,712, with no disclosed reserves policy target or material uncertainties regarding its ability to continue as a going concern. Its FY2024 accounts were audited.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE HOBSON CHARITY LIMITED | 4 | £45k |
| THE EDWARD GOSTLING FOUNDATION | 2 | £250k |
| SIR JULES THORN CHARITABLE TRUST | 2 | £11k |
| LILLIE JOHNSON CHARITABLE TRUST | 2 | £5k |
| THE EDGAR E LAWLEY FOUNDATION | 2 | £4k |
| THE MILLENNIUM OAK TRUST | 1 | — |
| MOONDANCE FOUNDATION | 1 | £132k |
| BRAIN TUMOUR RESEARCH | 1 | £128k |
Charities like this
- SUDC-UK
- SUICIDE & CO
- BRAIN TUMOUR SUPPORT
- AILSA'S AIM
- SUCCESS LIFE AFTER CURE LIMITED
- BRAIN TUMOUR RESEARCH
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| IN SUE'S NAME | £144k | — | 0 | unclear | — | no doubt |
| SUDC-UK | £401k | — | 0 | unclear | — | no doubt |
| SUICIDE & CO | £1.4m | — | — | unclear | 30.6% | no doubt |
| BRAIN TUMOUR SUPPORT | £575k | Under £60,000 | 0 | unclear | — | no doubt |
| AILSA'S AIM | £165k | — | 0 | above | — | no doubt |
| SUCCESS LIFE AFTER CURE LIMITED | £225k | — | 0 | unclear | — | no doubt |